Reported 0 shares, down 15 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-03-31 | 1377 |
| 2023-06-30 | 6014 |
| 2023-09-30 | 8808 |
| 2023-12-31 | 19790 |
| 2024-03-31 | 17372 |
| 2024-06-30 | 18506 |
| 2024-09-30 | 9611 |
| 2024-12-31 | 1113 |
| 2025-03-31 | 483 |
| 2025-06-30 | 613 |
| 2025-09-30 | 411 |
| 2025-12-31 | 22 |
| 2026-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2026 | Reduced | 0 | -15 (-100.0%) | 0 | $0 | 2026-05-15 | |
| Q4 2025 | Reduced | 15 | -445 (-96.7%) | < 0.01% | $22 | 2026-02-13 | |
| Q3 2025 | Added | 460 | +59 (14.7%) | < 0.01% | $411 | 2025-11-14 | |
| Q2 2025 | Added | 401 | +8 (2.0%) | < 0.01% | $613 | 2025-08-15 | |
| Q1 2025 | Added | 393 | +35 (9.8%) | < 0.01% | $483 | 2025-05-15 | |
| Q4 2024 | Reduced | 358 | -3,050 (-89.5%) | < 0.01% | $1,113 | 2025-02-14 | |
| Q3 2024 | Unchanged | 3,408 | 0 (0.0%) | < 0.01% | $9,611 | 2024-11-14 | |
| Q2 2024 | Reduced | 3,408 | -632 (-15.6%) | < 0.01% | $18,506 | 2024-08-14 | |
| Q1 2024 | Added | 4,040 | +442 (12.3%) | < 0.01% | $17,372 | 2024-05-15 | |
| Q4 2023 | Added | 3,598 | +1,658 (85.5%) | < 0.01% | $19,790 | 2024-02-13 | |
| Q3 2023 | Unchanged | 1,940 | 0 (0.0%) | < 0.01% | $8,808 | 2023-11-15 | |
| Q2 2023 | Unchanged | 1,940 | 0 (0.0%) | < 0.01% | $6,014 | 2023-08-14 | |
| Q1 2023 | New | 1,940 | +1,940 (0.0%) | < 0.01% | $1,377 | 2023-05-15 |
Who else reported the position
42 managers reported MARKER THERAPEUTICS INC for Q1 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| NEA Management Company LLC | Unchanged | 1,625,678 | 0 | 0.12% | $2,113,381 | 13 qtrs |
| Blue Owl Capital Holdings LP | Unchanged | 554,250 | 0 | 0.19% | $720,525 | 6 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | New | 389,319 | +389,319 | < 0.01% | $506,115 | 1 qtr |
| Aisling Capital Management LP | Unchanged | 325,370 | 0 | 0.09% | $422,981 | 12 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Added | 175,294 | +51,644 | < 0.01% | $227,882 | 13 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 160,910 | +30,566 | < 0.01% | $209,206 | 13 qtrs |
| ADVISOR GROUP HOLDINGS INC | Reduced | 93,121 | -1,300 | < 0.01% | $121,057 | 13 qtrs |
| VANGUARD FIDUCIARY TRUST CO | New | 87,269 | +87,269 | < 0.01% | $113,450 | 1 qtr |
| LPL Financial LLC | Reduced | 83,047 | -200 | < 0.01% | $107,961 | 6 qtrs |
| XTX Topco Ltd | Added | 63,567 | +5,526 | < 0.01% | $82,637 | 3 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2026
- Filed
- May 15, 2026
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.